INTEC PHARMA LTD. Deferred Tax Assets, Net of Valuation Allowance
INTEC PHARMA LTD. had Deferred Tax Assets, Net of Valuation Allowance of $504.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2020-03-13
- 2019-09-30: Deferred Tax Assets, Net of Valuation Allowance $504.00K.
- 2019-06-30: Deferred Tax Assets, Net of Valuation Allowance $429.00K.
- 2019-03-31: Deferred Tax Assets, Net of Valuation Allowance $350.00K.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $281.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2019-09-30 | $504.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $429.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $350.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $281.00K 10-K · filed 2020-03-13 |